| American Cancer Society guidelines on nutrition and physical activity for cancer prevention. LH Kushi, C Doyle, M McCullough, CL Rock, W Demark-Wahnefried, ... CA: a cancer journal for clinicians 62 (1), 2012 | 2751* | 2012 |
| Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study JM Chan, MJ Stampfer, E Giovannucci, PH Gann, J Ma, P Wilkinson, ... Science 279 (5350), 563-566, 1998 | 2696 | 1998 |
| Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends R Etzioni, DF Penson, JM Legler, D Di Tommaso, R Boer, PH Gann, ... Journal of the National Cancer Institute 94 (13), 981-990, 2002 | 1224 | 2002 |
| Prospective study of sex hormone levels and risk of prostate cancer PH Gann, CH Hennekens, J Ma, C Longcope, MJ Stampfer JNCI: Journal of the National Cancer Institute 88 (16), 1118-1126, 1996 | 1035 | 1996 |
| A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer PH Gann, CH Hennekens, MJ Stampfer Jama 273 (4), 289-294, 1995 | 995 | 1995 |
| Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis PH Gann, J Ma, E Giovannucci, W Willett, FM Sacks, CH Hennekens, ... Cancer research 59 (6), 1225-1230, 1999 | 988 | 1999 |
| Prostate specific antigen best practice statement: 2009 update KL Greene, PC Albertsen, RJ Babaian, HB Carter, PH Gann, M Han, ... The Journal of urology 189 (1), S2-S11, 2013 | 719 | 2013 |
| Role of diet in prostate cancer development and progression JM Chan, PH Gann, EL Giovannucci Journal of Clinical Oncology 23 (32), 8152-8160, 2005 | 553 | 2005 |
| Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer JM Chan, MJ Stampfer, J Ma, P Gann, JM Gaziano, M Pollak, ... Journal of the National Cancer Institute 94 (14), 1099-1106, 2002 | 544 | 2002 |
| Low-dose aspirin and incidence of colorectal tumors in a randomized trial PH Gann, JAE Manson, RJ Glynn, JE Buring, CH Hennekens JNCI: Journal of the National Cancer Institute 85 (15), 1220-1224, 1993 | 536 | 1993 |
| Abnormal glucose metabolism and pancreatic cancer mortality SM Gapstur, PH Gann, W Lowe, K Liu, L Colangelo, A Dyer Jama 283 (19), 2552-2558, 2000 | 529 | 2000 |
| Prospective study of plasma fatty acids and risk of prostate cancer PH Gann, CH Hennekens, FM Sacks, F Grodstein, EL Giovannucci, ... JNCI: Journal of the National Cancer Institute 86 (4), 281-286, 1994 | 486 | 1994 |
| Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies AW Roddam, NE Allen, P Appleby, TJ Key, L Ferrucci, HB Carter, ... Annals of internal medicine 149 (7), 461-471, 2008 | 448 | 2008 |
| Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study JM Chan, MJ Stampfer, J Ma, PH Gann, JM Gaziano, EL Giovannucci The American journal of clinical nutrition 74 (4), 549-554, 2001 | 444 | 2001 |
| Risk factors for prostate cancer PH Gann Reviews in urology 4 (Suppl 5), S3, 2002 | 426 | 2002 |
| Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia KT McVARY, A Rademaker, GL Lloyd, P Gann The Journal of urology 174 (4 Part 1), 1327-1333, 2005 | 373 | 2005 |
| Colorectal cancer mortality and factors related to the insulin resistance syndrome LA Colangelo, SM Gapstur, PH Gann, AR Dyer, K Liu Cancer Epidemiology Biomarkers & Prevention 11 (4), 385-391, 2002 | 333 | 2002 |
| Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study SM Gapstur, PH Gann, P Kopp, L Colangelo, C Longcope, K Liu Cancer Epidemiology Biomarkers & Prevention 11 (10), 1041-1047, 2002 | 306 | 2002 |
| Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. J Ma, MJ Stampfer, PH Gann, HL Hough, E Giovannucci, KT Kelsey, ... Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1998 | 275 | 1998 |
| A randomized trial of single-and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis PH Gann, FA Neva, AA Gam Journal of Infectious Diseases 169 (5), 1076-1079, 1994 | 271 | 1994 |
